Sartorius Aktiengesellschaft (ETR: SRT3)

Market Cap	15.77B
Revenue (ttm)	3.34B
Net Income (ttm)	78.00M
Shares Out	69.04M
EPS (ttm)	1.13
PE Ratio	224.20
Forward PE	86.81
Dividend	0.74 (0.29%)
Ex-Dividend Date	n/a

Volume	159,257
Open	251.00
Previous Close	248.30
Day's Range	249.20 - 257.70
52-Week Range	199.50 - 383.70
Beta	0.93
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 17, 2024

About SRT3

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quar...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 14,614
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: SRT3

Financial Performance

In 2023, SRT3's revenue was 3.40 billion, a decrease of -18.66% compared to the previous year's 4.17 billion. Earnings were 205.20 million, a decrease of -69.74%.